Published Date: 26 Apr 2023
According to recent studies, the prevalence of HIV is 2.5 times higher in South London's mental health service users than it is in the general population. The article was released today in BMJ Open.
Read Full NewsA lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.
An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.
1.
Year in Review: Multiple Myeloma
2.
Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness
3.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
4.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
5.
More People Than Previously Believed Have Schizophrenia.
1.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
2.
Progressive Updates in Oncology for Healthcare Excellence
3.
Bone Marrow Regenerative Capacity and Hematologic Recovery
4.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
5.
Immune Surveillance Screening for Early Cancer Risk Detection
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
4.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation